Office Action Predictor
Last updated: April 16, 2026
Application No. 19/369,905

METHODS AND DEVICES FOR MANIPULATING BIOLOGICAL SAMPLES

Non-Final OA §102
Filed
Oct 27, 2025
Examiner
MUTREJA, JYOTI NAGPAUL
Art Unit
1798
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Singular Genomics Systems, INC.
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
2y 11m
To Grant
88%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allow Rate
740 granted / 913 resolved
+16.1% vs TC avg
Moderate +6% lift
Without
With
+6.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
32 currently pending
Career history
945
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
34.6%
-5.4% vs TC avg
§102
50.6%
+10.6% vs TC avg
§112
10.3%
-29.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 913 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Lam (US 7405056). Regarding claim 1, Lam teaches a tissue punch comprising positioning a punch device (26) against a sample-carrier construct formed of a tissue section (29a) and carrier substrate (29b), the punch device (26) formed of an outer wall having a top edge, a bottom edge, and an internal lumen; pushing the bottom edge of the punch device through the sample-carrier construct to cut through the sample-carrier construct such that an excised tissue section is positioned within the internal lumen of the punch device to form a loaded punch device (refer to Figure 5); positioning the loaded punch device against a slide; positioning a piston relative to the loaded punch device so that the piston can be inserted into the loaded punch device; and using the piston to push the excised tissue section out of the loaded punch device toward the slide. (Refer to Col. 9, Lines 46-65) Regarding claim 2, the piston (10) is part of a piston array formed of a plurality of pistons (10). (Refer to Col. 6, Lines 27-35) Regarding claim 3, loading a plurality of loaded punch devices onto a corresponding plurality of pistons of the piston array. (Refer to Col. 6, Lines 27-35) Regarding claim 4, using the piston to push the excised tissue out of the loaded punch device toward the slide comprises using the piston array to simultaneously push excised tissues of a plurality of loaded punch devices toward the slide. (Refer to Col. 6, Lines 27-35) Regarding claim 5, incubating the slide. (Refer to Col. 17, Lines 45-56) Regarding claim 6, the slide is incubated while the loaded punch device is positioned on the slide. (Refer to Col. 17, Lines 45-56) Regarding claim 7, after incubating the slide, removing the loaded punch device from the slide such that the excised tissue section is retained on the slide. (Refer to Col. 14, Lines 21-34) Regarding claim 8, the slide is incubated on a heat plate. (Refer to Col. 17, Lines 45-56) Regarding claim 9, positioning the loaded punch device against a slide comprises positioning a top edge of the loaded punch device against the slide. (Refer to Col. 9, Lines 46-65) Regarding claim 10, the loaded punch device is positioned in a perpendicular orientation relative to the slide. (Refer to Col. 9, Lines 46-65) Regarding claim 11, removably attaching the punch device (26) to a punch tool (26’) formed an outer housing that removably receives the punch device, wherein the housing serves as a handle for manipulating the punch device. Regarding claim 12, the punch tool is a spring-loaded tool (41) that can be actuated by a user to expel, eject, or otherwise transition the punch device toward the sample carrier-construct. (Refer to Figure 6) Regarding claim 13, pushing the bottom edge of the punch device (26) through the sample-carrier construct comprises actuating the punch tool. (Refer to Figures 5 and 6) Regarding claim 14, the bottom edge of the punch device is sharp. (Refer to Figure 6) Regarding claim 15, the bottom edge of the punch device is a blade. (Refer to Col. 11, Lines 9-14) Regarding claim 16, the punch device (26) is cylindrical. (Refer to Col. 13, Lines 15-17) Regarding claim 17, the punch device is cuboid, cylindrical, pyramidal, conical, or frustoconical. (Refer to Col. 13, Lines 15-17) Regarding claim 18, the slide forms part of a flow cell. (Refer to Col. 1, Lines 55-62) Regarding claim 19, the carrier substrate comprises agarose, gelatin, polyacrylamide, or any suitable hydrogel. (Refer to Col. 10, Lines 47-49) Regarding claim 20, while the tissue sample remains in contact with the glass solid support, heating the glass solid support to a temperature of 30 °C or greater. (Refer to claim 1 rejection and Col. 17, Lines 50-55) Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JYOTI NAGPAUL whose telephone number is (571)272-1273. The examiner can normally be reached M-F 9am to 5pm, EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles Capozzi can be reached at 571-270-3638. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JYOTI Mutreja/Primary Examiner, Art Unit 1798
Read full office action

Prosecution Timeline

Oct 27, 2025
Application Filed
Feb 06, 2026
Non-Final Rejection — §102
Mar 23, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12596059
Automated Tissue Sectioning and Storage System
2y 5m to grant Granted Apr 07, 2026
Patent 12584827
FULL-AUTOMATIC PREPARATION METHOD OF CAST-OFF CELL SMEAR
2y 5m to grant Granted Mar 24, 2026
Patent 12578325
A staining method for live-cell imaging
2y 5m to grant Granted Mar 17, 2026
Patent 12569595
BIOPROSTHETIC TISSUE PREPARATION
2y 5m to grant Granted Mar 10, 2026
Patent 12570949
SYSTEMS AND DEVICES FOR WOUND THERAPY AND RELATED METHODS OF USE
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
88%
With Interview (+6.5%)
2y 11m
Median Time to Grant
Low
PTA Risk
Based on 913 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month